Loesch: I Wouldn't Have Made It Out of CNN Town Hall

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
404
Loesch: I Wouldn't Have Made It Out of CNN Town Hall Without Security Detail

< >

NRA spokeswoman Dana Loesch joined Sean Hannity live at CPAC Thursday night to react to CNN's Wednesday night town hall on gun violence.

During the event -- which was organized in the wake of the deadly Florida school shooting -- Loesch was confronted by victims' families and survivors, in addition to an extremely hostile crowd.

“You heard that town hall last night, they cheered the confiscation of firearms,” Loesch said at CPAC Thursday morning, noting there were thousands in attendance. "I had to have a security detail to get out. I wouldn’t have been able to exit that if I did not have a private security detail. There were people rushing the stage and screaming 'burn her.' And I came there to talk solutions.”

On "Hannity," Loesch said walking to the town hall stage at BB&T Center made her feel like boxer Floyd Mayweather making his way to the ring for a match.

"You came in through part of the arena and you walked through, between all these people, and you got up on stage. It was pretty chaotic," Loesch said, revealing that she had many horrible threats and insults thrown at her.

She added that as she walked out after the town hall concluded, she was met with chants of "shame!" like "Game of Thrones" character Cersei Lannister.

"If I did not have a three-person detail with me, I would not have gotten out of the arena," Loesch said.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Understanding Rollins' Current Market Position and Outlook

Updated Category News Views 226

Analyzing Rollins Inc.'s Stock Performance As we look at the current performance of Rollins Inc. (NYSE: ROL), the shares are trading around $55.73, reflecting a decrease of 1.24% in the recent session. While the stock has dipped by 3.81% over the past month, it has impressively increased by 10.91% year-over-year. This presents a curious juxtaposition of short-term...

Continue Reading
Silver One Reports Major Mineral Resource Estimate for Candelaria

Updated Category News Views 199

Candelaria Project Mineral Resource Estimate Silver One Resources Inc. (OTCQX: SLVRF) has made a significant announcement regarding the completion of a mineral resource estimate for the Candelaria Project. This estimate is prepared in accordance with the National Instrument 43-101, ensuring that the resources are assessed with high standards of transparency and accuracy....

Continue Reading
Investors Alert: Zynex (ZYXI) Faces Serious Legal Scrutiny

Updated Category News Views 197

Legal Investigation into Zynex, Inc. The Law Offices of Frank R. Cruz have announced a crucial investigation regarding Zynex, Inc. (ZYXI) focused on potential violations of federal securities laws. This investigation comes as a response to significant concerns raised about the company's recent financial disclosures and their implications for investors. Understanding the...

Continue Reading
Understanding Rentokil Initial's Stock Valuation Insights

Updated Category News Views 100

Assessing Rentokil Initial's Stock Performance In the current trading session, Rentokil Initial Inc. (NYSE: RTO) shares are priced at $26.42, witnessing a notable increase of 1.46%. Over the past month, the stock has gained 1.40%, though it has faced a decline of 7.78% in the last year. This fluctuation raises questions among shareholders regarding its valuation, despite...

Continue Reading
Innovative Insights on Efzofitimod from aTyr Pharma's Recent Conference

Updated Category News Views 177

aTyr Pharma Highlights Efzofitimod at Key Conference At a significant scientific gathering, aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology firm known for its innovative therapeutic approaches, shared compelling data concerning efzofitimod. This presentation underlined important insights about the treatment of pulmonary sarcoidosis. The conference, which...

Continue Reading